Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM‐REDUCE‐AF trial)

• Published in: Annals of noninvasive electrocardiology Vol. 28; no. 2; pp. e13043 - n/a
• Main Authors: Tankut, Sinan S., Huang, David T., Zareba, Wojciech, Aktas, Mehmet K., Rosero, Spencer Z., Steinberg, Jonathan, Henchen, Jennifer, Kutyifa, Valentina, Strawderman, Robert L., Goldenberg, Ilan
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.03.2023; John Wiley and Sons Inc; Wiley
• Subjects: Ablation; Applications programs; Asymptomatic; atrial fibrillation; Atrial Fibrillation - diagnosis; Atrial Fibrillation - surgery; Blood clots; Cardiac arrhythmia; catheter ablation; Catheter Ablation - methods; Catheters; Clinical Protocols; Clinical trials; Contraindications; Customization; Electrocardiography; Emergency medical care; Fibrillation; Health care; Health services utilization; Heart; Hospitalization; Humans; Informed consent; insertable cardiac monitor; Intervention; Medical instruments; Mobile computing; Mortality; Original; Patients; Pulmonary Veins; Quality of Life; Questionnaires; Radiofrequency ablation; Randomization; Randomized Controlled Trials as Topic; Recurrence; remote monitoring; Substrates; Surgery; Treatment Outcome; New York; United States > US; atrial fibrillation; catheter ablation; remote monitoring; insertable cardiac monitor

Background Percutaneous catheter ablation (CA) to achieve pulmonary vein isolation is an effective treatment for drug‐refractory paroxysmal and persistent atrial fibrillation (AF). However, recurrence rates after a single AF ablation procedure remain elevated. Conventional management after CA ablati...